Cardiology is entering a new era. The revolution in genomics, together with the rapid rise of artificial intelligence, is redefining our ability to understand disease and to develop targeted, personalized therapies. At the same time, these advances concentrate a form of power that humanity has rarely encountered before: the power of biological knowledge, large-scale data, and computational intelligence. The central question of our time is clear: will these technologies become instruments of collective progress, or mechanisms that deepen global and social inequalities?
Our conference “Genetics and Precision Medicine in Cardiology” organized by Onassis Hospital in collaboration with the Greek Network on Precision Medicine in Cardiology and The International Cardiomyopathy Network (ICoN) is not simply another scientific meeting. It is an invitation to reflect on how our ability to diagnose and manage people with inherited cardiovascular disease will evolve in the 21st Century.
Across the different sessions of the meeting, from genetic testing and diagnosis to the implementation of precision cardiology in health systems, international experts will explore how these advances are already changing clinical practice.
The participation of the World Heart Federation highlights the global relevance of inherited disease and during the conference, an important statement will be presented on the current status of genetic testing today.
Genetic knowledge cannot remain the privilege of the few. The knowledge derived from the human genome, and the transformative power generated by artificial intelligence, must serve the common good. For this reason, this conference places at its core the urgent need for the democratic governance of biomedical knowledge. This means advancing open science, ensuring equitable access to genetic testing, guaranteeing transparency in the use of health data, and enabling societies to participate in decisions that will shape the future of medicine.
“Genetics and Precision Medicine in Cardiology” is a call to the scientific community, to health systems, and to society at large to ensure that the genomic revolution becomes, through the daily practice, a revolution of equity, access, and life.
